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Objectives: Fournier’s gangrene (FG) is an devastating disease that affects the perineum and genitourinary region,
and is commonly a result of poly-microbial infection. This study is aimed to determine the correlation between
micrology and prognosis of FG in the past five years.
Methods: This study was a retrospective cohort study that was designed to study the trends in micrology and
prognosis of FG. From the PubMed database, articles published in the recent 5 years (from Jan1st, 2009 to Dec 31st,
2013) were reviewed. A total of 19 articles (each with n > 30 and with thorough data descriptions in the topic of
Fournier's gangrene), were enrolled in this study. The consolidated data was further analyzed by commercial
statistical software (SPSS for Windows).
Results: The twenty-two studies have covered FG cases from year 1981 to 2011, with a mean duration of 9.2 years.
The total number of cases is 4,365. Majority of the cases are male (84.1%). The mean age and mortality rate is
51.8 ± 5 years old and 11.1 ± 8.9%, respectivly. The most commonly found pathogen is poly-microbial organism
(54%), followed by Escherichia coli (46.6%) and Streptococcus (36.8%). The major risk factors are diabetes (43.7%),
Body mass index of > 30 (40.7%), and hypertension (38.1%). Mortality rate in older patient group (age > 51.8 years
old) is significantly higher than those of the younger group (22% vs. 5.5%, p = 0.0001).
Conclusions: Older patients with genital or perineal pain should be examined for crepitus dermis. When a patient is
diagnosed with FG, swift consultation with surgeons and administration of broad-spectrum antibiotics are required in
order to save the patient’s live.
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Fournier’s gangrene (FG) is a devastating necrotising dis-
ease that affects the perineum and genitourinary regions.
The common cause of FG is poly-microbial infections,
where the diabetes mellitus is an attributing common
risk factor (Shyam and Rapsang 2013). Study has shown
that males, especially in their 60 to 70s, are more often
affected by FG when compared to other populations
(Rodríguez Alonso et al. 2000). Aside from diabetes,
other risk factors of FG also include chronic alcoholism,
renal failure, and obesity (Montoya Chinchilla et al.
2009). The majorities of FG studies have shown that* Correspondence: yjsu.md@msa.hinet.net
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in any medium, provided the original work is pearly diagnosis and aggressive management of FG are
required to significantly improve patient outcome. Due to
the fact that FG is not a common disease, a prospective
study is difficult to perform. Therefore, In this study, a
large number of FG cases that have occurred in the past
five years are gathered by retrospective literature review
and analyzed to determined the relationship between
micrology and prognosis of FG.Methods
A retrospective cohort study was designed to investigate
the correlation between micrology and prognosis of FG.
A search from the PubMed database returned a total of
1,015 literatures that contain the keyword “Fournier’s
gangrene”. The resulting literatures were further limited
to the literature s that were published within the past
5 years, (from Jan.1, 2009 to Dec 31, 2013), where a totalOpen Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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numbers of less than 30 were excluded from the study,
since the low sample number cannot establish a normal
distribution for the evaluation of statistical significance.
In the end, there were 19 articles that was enrolled into
this study. The combined data and descriptions of
Fournier’s gangrene are listed in Table. 1 References
(Martinschek et al. 2012) to (Ersoz et al. 2012). These
enrolled research literatures are from Germany (n = 4,
21%), Turkey (n = 4), United States of America (n = 2),
Pakistan (n = 2), Spain (n = 2), Mexico (n = 1), Brazil
(n = 1), Taiwan (n = 1), Tunisia (n = 1) and Croatia (n = 1).
The data was analyzed with a commercial statistical soft-
ware (SPSS for Windows, version 11.0, SPSS Ltd., Chicago,
IL). Statistical χ2 tests were performed and the significance
was set at a p value of less than 0.05 (2-tailed).
Results
The twenty-two studies have covered FG cases from year
1981 to 2011, with a mean duration of 9.2 years. The
total number of cases is 2,656. Majority of cases are male
(84.1%) and female is accounted for 15.9%.
The mean age of the patients is 51.8 years old, and the
average mortality rate is 11.1 ± 8.9%. When comparing
between the older age group (age > 51.8 years old) and
the younger group (age of less or equal to 51.8), the
mortality rate was found to be higher in the older groupTable 1 There were 19 articles (from January 1, 2009 to Dece
Duration Duration [years] First author Country
1981 ~ 2010 29 Martinschek et al. (2012) Germany
1994 ~ 2006 12 Macro et. al. (2010) Spain
1995 ~ 2010 15 Sallami et a. (2012) Tunisia
1995 ~ 2010 15 Altarac et al. (2012) Croatia
1996 ~ 2006 10 Yilmazlar et al. (2010) Turkey
1996 ~ 2006 10 Ozturk et al. (2011) Turkey
1996 ~ 2008 12 Czymek et al. (2010) Germany
1998 ~ 2006 8 MEHL et al. (2010) Brazil
1999 ~ 2009 10 Koukouras et al. (2011) Germany
2000 ~ 2008 8 Malik et al. (2010) Pakistan
2000 ~ 2008 8 Chen et al. (2011) Taiwan
2001 ~ 2004 4 Sorensen et al. (2009) USA
2001 ~ 2011 10 Roghmann et al. (2012) Germany
2002 ~ 2007 5 Morua et al. (2009) Mexico
2002 ~ 2007 5 Ullah et al. (2009) Pakistan
2003 ~ 2008 5 Vargas et al. (2011) Spain
2004 ~ 2010 36 GÖKTAŞ et al. (2012) Turkey
2004 ~ 2011 7 Bjurlin et al. (2013) USA
2005 ~ 2008 3 Ersoz et al. (2012) Turkey
The combined data and descriptions of Fournier’s gangrene are listed in Table 1.
NA = Not Available.than younger (22 ± 8.8% versus 5.5 ± 2%, p = 0.0001) The
most commonly found pathogen is poly-microbial or-
ganism (54%), followed by Escherichia coli (46.6%) and
Streptococcus (36.8%). The other contributing pathogens
also include Bacteroides, Enterbacter, Staphylococcus,
Enterococcus, Pseudomonas, Corynebacterium, and Kleb-
siella pneumoniae (Figure 1).
The major risk factors for FG are diabetes (43.7%), body
mass index of higher than 30 (40.7%), and hypertension
(38.1%). Other risk factors also include heart disease
(38%), alcoholism (31.4%), smoking (22.5%), renal failure
(13.8%), urethral operation history, neurogenic bladder,
and corticosteroid user (Figure 2).Discussion
Fournier’s gangrene (FG) is a rare emergent condition
that affects the perineum and urogenital region. The
clinical course of FG is fulminant and serious regardless of
parenteral antibiotic treatment. The median time from syp-
tom presentations to skin gangrenous change is 6 days
(Altarac et al. 2012). When managing FG patients, this
gangrenous tissue requires extensive and repeated debride-
ment (Sallami et al. 2012). Several literatures have shown
that patients with diabetes, old age, low blood pressure,
high creatine kinase, high lactate, abdominal affection,
hemoglobin of less than 10 g/dL, and platelet count of lessmber 31, 2013) enrolled into this study
Number Male % Female % Mean age Mortality rate %
55 61.8 38.2 48 16.4
51 94 6 63 16
40 NA NA 52.8 17.5
41 95 5 62 36.6
80 71.3 28.7 57 21
44 52.3 47.7 57 36.3
38 NA NA 57.7 21.1
40 77 23 47.2 20
45 88.9 11.1 50 15.6
73 91.8 8.2 57.3 17.8
50 NA NA 53.6 12
1680 97.7 2.3 50.9 7.5
44 NA NA 59 30
63 96 4 47.5 12
60 83.3 16.7 47 7
42 100 0 51 17
36 NA NA 55.5 11.1
122 97.6 2.4 49 4.9
52 69 31 55 23.8
Figure 1 List of commonly found pathogens involving Fournier’s gangrene (presented in percentages).
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(Martinschek et al. 2012; Ruiz-Tovar et al. 2012).
Many literatures have determined that the risk factors
of FG include diabetes mellitus, hypertension, heart dis-
ease, smoking, long-term steroid therapy, alcoholism or
alcohol abuse, in hot and humid season, and renal failure
(Martinschek et al. 2012; Sallami et al. 2012; Czymek
et al. 2010; Mehl et al. 2010; Malik et al. 2010; Ullah and
Khan 2009). Out of the many risk factors, diabetes melli-
tus is still the highest influencing factor on FG where
43.7% of FG patients are diabetic. A report by Czymek
et. al. showed that being overweight is also a risk factor
of FG, where nearly 40 % of FG patients have body mass
indexes (BMIs) of higher than 30 (Czymek et al. 2010;
Mehl et al. 2010). Although there are several known risk
factors that can lead to the development of FG, the clin-
ical onset of FG is still unpredictable.
The most common symptoms of FG are perineal pain
and fever that are accompanied by swelling and reddeningFigure 2 List of commonly found risk factors involving Fournier’s ganof perineum or genital area, and the gangreneous change
of overlaying skin (Ruiz-Tovar et al. 2012).
The most common microbiology involved in FG is poly-
microbial infection (54%), and the most common found
pathogen isolate is Escherichia coli (46.6%). Others con-
tributing pathogen are Streptococcal infection, Bacteroides,
Enterobacter, Staphylococcus, Enterococcus, Pseudomonas,
Corynebacterium, and Klebsiella pneumoniae (Rodríguez
Alonso et al. 2000; Czymek et al. 2010; Mehl et al. 2010).
Broad-spectrum antibiotic treatment is suggested to ad-
equately cover poly-microbial pathogen, and careful patient
monitoring is required to avoid is fungal or hospital-
acquired pathogen infection (Bjurlin et al. 2013).
In terms of gender, there was no significant mortality
rate that was found between the genders (Ersoz et al.
2012). A study from Spain (n = 51) showed that the survi-
vors of FG are 13.5 years younger than those who have
died (60 versus 73.5, p = 0.02) (Luján Marco et al. 2010).
In a 2012 report from Turkey ( n = 52), the non-survivorsgrene (presented in percentages).
Tang et al. SpringerPlus  (2015) 4:14 Page 4 of 4group are older in age than survivors (62 versus 55 years
old]. In our study, the results also showed that the older
patients age had higher rates of mortality. This result is
concurrent with in the other previous studies, where
increased age was shown to be related to higher mortality
rate (Martinschek et al. 2012; Roghmann et al. 2012).
Although FG is rare, its rapid progression can lead to
life-threatening conditions that require early surgical
intervention and parenteral antibiotics to improve patient
outcomes (Morua et al. 2009). The mortality rate of FG
remains high and ranges from 4.9 to 36.6% in the recent
five years. Due to its high mortality rate and rapid pro-
gress, FG must be regarded in clinical settings. The
reduction of obesity, alcohol consumption, tobacco use
is helpful in reducing the possible risk of FG. Furthermore,
older patients with genital or perineal pain should be
examined for crepitus dermis. Finally, when a patient is
diagnosed with FG, swift consultation with surgeons and
administration of broad-spectrum antibiotics are required
in order to save the patient’s live.
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